Bernard A. Fox/LinkedIn
Bernard A. Fox, Co – founder, President, and CEO of UbiVac, shared a post on LinkedIn:
“Leaving Logan Airport outside Boston and headed home to Portland! What a great 4 days. Agenus , Kelonia Therapeutics, and the IO360Summit!
Hats off to James Gulley, Axel Hoos for their work organizing the program! Also, congrats to Kate Woda and her team on a spectacularly well organized and run conference..
While flying home I am going to write another post or two about some of what I got out of this very unique meeting. As a proud member of the following 4 societies – let me say IO360 fills a gap and It is different than AACR, SITC, ASCO, ESMO – It is small, less than 500 attendees, and you can find, connect, and speak with any of the speakers.
In addition to the speakers in attendance was a spectrum of CSO and CEOs mingling with leading academics, senior BD folks from large Pharma, investment bankers, and biotech/pharma analysts.. Overall a great meeting for building bridges and figuring out how to move science and possible cures into patients Faster!”
Other articles featuring Bernard A. Fox on OncoDaily.